Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from Quipt Home Medical ( (TSE:QIPT) ) is now available.
Quipt Home Medical Corp. is set to announce its fiscal third-quarter 2025 financial results on August 11, 2025, with a conference call scheduled for the following day. This announcement is significant as it provides insights into the company’s financial health and operational progress, potentially impacting its market positioning and stakeholder interests.
The most recent analyst rating on (TSE:QIPT) stock is a Buy with a C$8.50 price target. To see the full list of analyst forecasts on Quipt Home Medical stock, see the TSE:QIPT Stock Forecast page.
Spark’s Take on TSE:QIPT Stock
According to Spark, TipRanks’ AI Analyst, TSE:QIPT is a Outperform.
Quipt Home Medical’s overall score is driven by strong financial performance in terms of revenue growth and cash flow management, despite profitability challenges. Technical analysis shows positive momentum, but valuation metrics are constrained by net losses. The earnings call reflects mixed sentiments with strategic initiatives for improvement.
To see Spark’s full report on TSE:QIPT stock, click here.
More about Quipt Home Medical
Quipt Home Medical Corp. is a U.S.-based provider of home medical equipment, focusing on end-to-end respiratory care. The company offers in-home monitoring and disease management services, targeting patients with chronic conditions such as heart or pulmonary disease, sleep disorders, and reduced mobility. Its primary business objective is to enhance shareholder value by expanding its range of services and increasing annual revenue per patient through service consolidation.
Average Trading Volume: 41,578
Technical Sentiment Signal: Sell
Current Market Cap: C$128.2M
Find detailed analytics on QIPT stock on TipRanks’ Stock Analysis page.